Altered transforming growth factor-β pathway expression pattern in rat endometrial cancer

Cancer Genetics and Cytogenetics

Volumn 177, Issue 1, 2007, Pages 43-50

  Karlsson, Sandra ^a   Holmberg, Erik ^a   Askerlund, Anders ^a   Levan, Karin Klinga ^a  

^a UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CARCINOGENESIS; CELL TYPE; DNA MICROARRAY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 34547693516     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.05.010     Document Type: Article

References (40)

1. Gruber S.B., and Thompson W.D. A population-based study of endometrial cancer and familial risk in younger women. Cancer and steroid hormone study group. Cancer Epidemiol Biomarkers Prev 5 (1996) 411-417
2. Emons G., Fleckenstein G., Hinney B., Huschmand A., and Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7 (2000) 227-242
3. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 35 (2004) 649-662
4. Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol 13 (2000) 285-294
5. Deligdisch L., and Holinka C.F. Endometrial carcinoma: two diseases?. Cancer Detect Prevent 10 (1987) 237-246
6. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 (1983) 10-17
7. Deerberg F.K.J. Endometrial carcinoma in BDII/Han rats: model of a spontaneous hormone-dependent tumor. J Natl Cancer Inst 78 (1987) 1245-1251
8. Kaspareit-Rittinghausen J., Deerberg F., and Rapp K. Mortality and incidence of spontaneous neoplasms in BDII/Han rats. Z Versuchstierkd 30 (1987) 209-216
9. Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer 10 (2003) 23-42
10. Massague J. TGF-beta signal transduction. Annu Rev Biochem 67 (1998) 753-791
11. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1 (2000) 169-178
12. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
13. Markowitz S.D., and Roberts A.B. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7 (1996) 93-102
14. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
15. Blobe C.G., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 (2000) 1350-1358
16. Gold L.I., and Parekh T.V. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma. Semin Reprod Endocrinol 17 (1999) 73-92
17. Levy L., and Hill C.S. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17 (2006) 41-58
18. Bierie B., and Moses H.L. TGF-beta and cancer. Cytokine Growth Factor Rev 17 (2006) 29-40
19. Jakowlew S.B. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25 (2006) 435-457
20. Sakaguchi J., Kyo S., Kanaya T., Maida Y., Hashimoto M., Nakamura M., Yamada K., and Inoue M. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer. Gynecol Oncol 98 (2005) 427-433
21. Parekh T.V., Gama P., Wen X., Demopoulos R., Munger J.S., Carcangiu M.L., Reiss M., and Gold L.I. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 62 (2002) 2778-2790
22. Helou K., Walentinsson A., Beckmann B., Johansson A., Hedrich H.J., Szpirer C., Klinga-Levan K., and Levan G. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization. Cancer Genet Cytogenet 127 (2001) 118-127
23. Saal L.H., Troein C., Vallon-Christersson J., Gruvberger S., Borg A., and Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 3 (2002) SOFTWARE0003
24. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 6 (1990) 597-641
25. Abraham D.J., Shiwen X., Black C.M., Sa S., Xu Y., and Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 275 (2000) 15220-15225
26. Verrecchia F., Chu M.L., and Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276 (2001) 17058-17062
27. Inagaki Y., Truter S., and Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269 (1994) 14828-14834
28. Chung K.Y., Agarwal A., Uitto J., and Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 271 (1996) 3272-3278
29. Chen S.J., Artlett C.M., Jimenez S.A., and Varga J. Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene 215 (1998) 101-110
30. Chen S.J., Yuan W., Mori Y., Levenson A., Trojanowska M., and Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol 112 (1999) 49-57
31. Jussila T., Kauppila S., Bode M., Tapanainen J., Risteli J., Risteli L., Kauppila A., and Stenback F. Synthesis and maturation of type I and type III collagens in endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 115 (2004) 66-74
32. Xie S., Sukkar M.B., Issa R., Oltmanns U., Nicholson A.G., and Chung K.F. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288 (2005) L68-L76
33. Grotendorst G.R., Okochi H., and Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7 (1996) 469-480
34. Moussad E.E., Rageh M.A., Wilson A.K., Geisert R.D., and Brigstock D.R. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig. Mol Pathol 55 (2002) 186-192
35. Abreu J.G., Ketpura N.I., Reversade B., and De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4 (2002) 599-604
36. Kahai S., Vary C.P., Gao Y., and Seth A. Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts. Matrix Biol 23 (2004) 445-455
37. Birk D.E., Fitch J.M., Babiarz J.P., Doane K.J., and Linsenmayer T.F. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95 Pt 4 (1990) 649-657
38. Wenstrup R.J., Florer J.B., Brunskill E.W., Bell S.M., Chervoneva I., and Birk D.E. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279 (2004) 53331-53337
39. Krohn K. TGF-beta1-dependent differential expression of a rat homolog for latent TGF-beta binding protein in astrocytes and C6 glioma cells. Glia 25 (1999) 332-342
40. Shibanuma M., Mashimo J., Kuroki T., and Nose K. Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269 (1994) 26767-26774